Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Cancer, Nonmedullary”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT05507775
What this trial is testing

Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma

Who this might be right for
Non-Medullary Thyroid Carcinoma
Radboud University Medical Center 8
Not applicableStudy completedNCT05280379
What this trial is testing

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Who this might be right for
Thyroid Cancer, NonmedullaryColon Carcinoma
Radboud University Medical Center 33
Not applicableStudy completedNCT03397238
What this trial is testing

Myeloid Cell Reprogramming in Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Radboud University Medical Center 41
Not applicableEnded earlyNCT05014698
What this trial is testing

IDEntification of New Predisposition Genes in Differentiated THYroid Cancer

Who this might be right for
Differentiated Thyroid CancerThyroid Cancer, Nonmedullary
Nantes University Hospital 34
Not applicableStudy completedNCT00068497
What this trial is testing

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Who this might be right for
Anaplastic Thyroid CancerInsular Thyroid CancerMetastatic Parathyroid Cancer+83 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00887107
What this trial is testing

Sorafenib as Adjuvant to Radioiodine Therapy in Non-Medullary Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
Leiden University Medical Center 32
Not applicableUnknownNCT05989555
What this trial is testing

Effects of Radioactive Iodine on the Immune System in Thyroid Cancer

Who this might be right for
Thyroid Carcinoma, Nonmedullary
Radboud University Medical Center 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03690388
What this trial is testing

Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Who this might be right for
Differentiated Thyroid Cancer
Exelixis 187